Toxicity on spermatogenesis may not be a major concern for boys with severe sickle cell disease who require hydroxyurea treatment before puberty, according to results of a study published in Blood.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.